1
Conclusion: Pathologic response predicts survival after preoperative chemotherapy and resection of CLM.
2
Our study is the largest published series evaluating pCRs after preoperative chemotherapy.
3
Results: In the preoperative chemotherapy study, 167 patients were operated on.
4
Pretherapeutic clinical parameters were correlated with histopathologic response to preoperative chemotherapy.
5
Disease was staged before initiation of preoperative chemotherapy and before surgery.
6
Conclusions: Response to preoperative chemotherapy is significantly higher for patients with endocrine nonresponsive tumors.
7
Several studies have addressed the feasibility and efficacy of preoperative chemotherapy followed by surgery.
8
Following preoperative chemotherapy, 34 patients with local-regional disease underwent exploration.
9
We identified 10 protein spots associated with the chemosensitivity of osteosarcoma to preoperative chemotherapy.
10
Several randomized trials have compared preoperative chemotherapy with postoperative surgery.
11
Purpose: The purpose of this research was to identify factors predicting response to preoperative chemotherapy.
12
Background: Assessment of the responses of osteosarcoma patients to preoperative chemotherapy is of clinical importance.
13
Patients were randomised between either surgery or preoperative chemotherapy.
14
Receipt of preoperative chemotherapy was highly associated with downstaging.
15
She was diagnosed with Stage Ⅳ right ovarian cancer and was treated with preoperative chemotherapy.
16
The increase from two to four preoperative chemotherapy cycles did not increase the pathological response rate.
